EP Patent

EP4685151A1 — Proteasome inhibitor

Assigned to Max Planck Gesellschaft zur Foerderung der Wissenschaften eV · Expires 2026-01-28 · 0y expired

What this patent protects

Proteasome inhibitors of formula I, wherein the meanings for the various substituents are as disclosed in the description. The warhead is extended with a moiety facilitating pi-pi-interaction with Tyr169

USPTO Abstract

Proteasome inhibitors of formula I, wherein the meanings for the various substituents are as disclosed in the description. The warhead is extended with a moiety facilitating pi-pi-interaction with Tyr169

Drugs covered by this patent

Patent Metadata

Patent number
EP4685151A1
Jurisdiction
EP
Classification
—
Expires
2026-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.